Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Development and validation of a harmonized memory score for multicenter Alzheimer's disease and related dementia research.

Alzheimer's research & therapy·2026
Same author

Associations among sleep quality, cognitive decline, and Alzheimer's disease pathology in older adults: A longitudinal study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Combining plasma biomarkers and cognitive challenge tests enhances prediction of functional trajectories of decline among older adults with cognitive impairment.

Journal of Alzheimer's disease : JAD·2026
Same author

Common Medical Comorbidities, Demographic Factors and Levels of Plasma Biomarkers of Alzheimer's Disease and Neurodegeneration in Black/African American Older Adults.

Biomolecules·2026
Same author

Detecting Cognitive Impairment in African American Older Adults Using the LASSI-L and Plasma P-Tau<sub>217</sub>.

Advances in Alzheimer's disease·2026
Same author

Effects of care partner type on outcomes from a multicomponent behavioral intervention for mild cognitive impairment.

Alzheimer's & dementia (New York, N. Y.)·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Monica Rosselli1,2, Warren W Barker2,3, Merike Lang1

  • 1Florida Atlantic University, Davie, FL, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

白质高强度 (WMHs) 与神经退行有关,年龄和大脑缩是关键预测因素,而不是心血管风险因素. 这项研究发现,西班牙裔和非西班牙裔白人之间没有WMH或其预测因素的种族差异.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 神经成像是一种神经成像.
  • 痴呆症研究 痴呆症研究

背景情况:

  • 白质高强度 (WMHs) 与阿尔茨海默病 (AD) 和血管痴呆症有关.
  • 有限的研究存在于与心血管 (CV) 风险因素或AD病理学相关的WMH体积的种族差异.
  • 在美国研究中,西班牙裔的代表性不足,研究了跨种族群体的WMH严重程度.

研究的目的:

  • 分析人口,文化,心血管风险因素和AD生物标志物来预测WMH严重程度.
  • 为了比较西班牙裔和非西班牙裔白人 (非HW) 人口之间的WMH严重程度及其预测因素.

主要方法:

  • 利用来自1佛罗里达ADRC研究的数据,包括252名西班牙裔和172名非HW参与者跨越认知状态.
  • 采用线性回归模型,视觉WMH体积作为依赖变量.
  • 包括种族,年龄,性别,教育,心血管因子,大脑缩,粉样蛋白PET状态和血p-tau217作为独立变量;语言能力和同文化是西班牙裔群体特有的.

主要成果:

  • 在族群之间没有发现心血管风险因素的显著差异.
  • 在总体样本中,年龄较大,阳性粉样蛋白PET状态,高的p-tau217,以及较大的海马和皮质缩预测了更高的WMH得分.
  • 年龄,海马缩和扩散皮质缩在总样本的多重回归模型中是显著的预测因素;种族不是一个显著的预测因素.

结论:

  • 主要预测WMH的严重程度是年龄和神经退行症 (大脑缩) 的测量,而不是心血管风险因素.
  • 在西班牙裔和非西班牙裔白人之间没有观察到WMH或CV风险因素的显著差异.
  • 研究结果表明,WMH与不同种族的神经退行有关.